Danaher Future Growth
Future criteria checks 2/6
Danaher is forecast to grow earnings and revenue by 14.3% and 7% per annum respectively. EPS is expected to grow by 14.6% per annum. Return on equity is forecast to be 10.9% in 3 years.
Key information
14.3%
Earnings growth rate
14.6%
EPS growth rate
| Life Sciences earnings growth | 0% |
| Revenue growth rate | 7.0% |
| Future return on equity | 10.9% |
| Analyst coverage | Good |
| Last updated | 27 Aug 2024 |
Recent future growth updates
No updates
Recent updates
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 27,682 | 5,846 | 7,408 | 8,473 | 18 |
| 12/31/2025 | 25,664 | 5,082 | 6,408 | 7,578 | 23 |
| 12/31/2024 | 23,771 | 4,242 | 5,625 | 6,344 | 23 |
| 6/28/2024 | 23,568 | 4,056 | 5,081 | 6,447 | N/A |
| 3/29/2024 | 23,737 | 4,069 | 5,548 | 6,956 | N/A |
| 12/31/2023 | 23,890 | 4,200 | 5,781 | 7,164 | N/A |
| 9/29/2023 | 22,275 | 4,597 | 6,831 | 8,086 | N/A |
| 6/30/2023 | 23,065 | 5,019 | 7,257 | 8,424 | N/A |
| 3/31/2023 | 24,904 | 5,757 | 7,364 | 8,498 | N/A |
| 12/31/2022 | 26,643 | 6,222 | 7,401 | 8,519 | N/A |
| 9/30/2022 | 31,250 | 6,640 | 7,068 | 8,311 | N/A |
| 7/1/2022 | 30,816 | 6,206 | 7,051 | 8,335 | N/A |
| 4/1/2022 | 30,283 | 6,206 | 7,162 | 8,455 | N/A |
| 12/31/2021 | 24,802 | 5,283 | 7,118 | 8,358 | N/A |
| 10/1/2021 | 28,065 | 5,636 | 7,056 | 8,246 | N/A |
| 7/2/2021 | 26,720 | 5,361 | 6,876 | 7,935 | N/A |
| 4/2/2021 | 24,799 | 4,595 | 6,351 | 7,260 | N/A |
| 12/31/2020 | 22,284 | 3,510 | 5,417 | 6,208 | N/A |
| 10/2/2020 | 20,392 | 3,083 | 4,444 | 5,099 | N/A |
| 7/3/2020 | 18,886 | 2,853 | 3,712 | 4,341 | N/A |
| 4/3/2020 | 18,034 | 2,614 | 3,439 | 4,068 | N/A |
| 12/31/2019 | 17,911 | 2,364 | 3,316 | 3,952 | N/A |
| 9/27/2019 | 15,562 | 2,093 | 3,479 | 4,078 | N/A |
| 6/28/2019 | 16,037 | 2,145 | 3,446 | 4,032 | N/A |
| 3/29/2019 | 16,573 | 2,166 | 3,311 | 3,896 | N/A |
| 12/31/2018 | 17,049 | 2,406 | 3,438 | 4,022 | N/A |
| 9/28/2018 | 19,615 | 2,761 | 3,004 | 3,619 | N/A |
| 6/29/2018 | 19,290 | 2,669 | 3,167 | 3,772 | N/A |
| 3/30/2018 | 18,819 | 2,553 | N/A | 3,747 | N/A |
| 12/31/2017 | 15,519 | 2,172 | N/A | 3,478 | N/A |
| 9/29/2017 | 17,828 | 2,360 | N/A | 3,292 | N/A |
| 6/30/2017 | 17,432 | 2,191 | N/A | 3,038 | N/A |
| 3/31/2017 | 17,164 | 2,051 | N/A | 3,309 | N/A |
| 12/31/2016 | 16,882 | 2,153 | N/A | 3,522 | N/A |
| 9/30/2016 | 16,621 | 1,927 | N/A | 4,104 | N/A |
| 7/1/2016 | 16,001 | 1,905 | N/A | 4,239 | N/A |
| 4/1/2016 | 13,663 | 1,775 | N/A | 4,051 | N/A |
| 12/31/2015 | 14,434 | 1,747 | N/A | 3,802 | N/A |
| 10/2/2015 | 15,335 | 1,875 | N/A | 3,810 | N/A |
| 7/3/2015 | 16,530 | 2,177 | N/A | 3,873 | N/A |
| 4/3/2015 | 19,186 | 2,521 | N/A | 3,771 | N/A |
| 12/31/2014 | 12,867 | 1,639 | N/A | 3,758 | N/A |
| 9/26/2014 | 19,197 | 2,683 | N/A | 3,597 | N/A |
| 6/27/2014 | 19,159 | 2,599 | N/A | 3,553 | N/A |
| 3/28/2014 | 19,336 | 2,583 | N/A | 3,460 | N/A |
| 12/31/2013 | 18,283 | 2,591 | N/A | 3,585 | N/A |
| 9/27/2013 | 18,827 | 2,536 | N/A | 3,307 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: DHR's forecast earnings growth (14.3% per year) is above the savings rate (8.5%).
Earnings vs Market: DHR's earnings (14.3% per year) are forecast to grow slower than the PE market (14.8% per year).
High Growth Earnings: DHR's earnings are forecast to grow, but not significantly.
Revenue vs Market: DHR's revenue (7% per year) is forecast to grow faster than the PE market (3.6% per year).
High Growth Revenue: DHR's revenue (7% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: DHR's Return on Equity is forecast to be low in 3 years time (10.9%).